Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index - ScienceDirect
The mean Vitiligo Area Scoring Index (VASI) score with standard error... | Download Scientific Diagram
PDF] Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. | Semantic Scholar
The mean Vitiligo Area Scoring Index (VASI) score with standard error... | Download Scientific Diagram
Measurement instrument used to score the Vitiligo Signs of Activity... | Download Scientific Diagram
BAD 2022 - Phase 2 Vitiligo Study (156-week data)
Vitiligo Area Scoring Index (VASI) of total skin and area specific, and... | Download Table
Patients with nonsegmental vitiligo see significant repigmentation with povorcitinib
Effect of Vitiligo Area Scoring Index on the quality of life in patients with vitiligo Hammam MA, Yasien HA, Algharably AF - Menoufia Med J
Effect of Vitiligo Area Scoring Index on the quality of life in patients with vitiligo Hammam MA, Yasien HA, Algharably AF - Menoufia Med J
Vitiligo Area Scoring Index (VASI) of total skin and area specific, and... | Download Table
Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI) | Dermatology and Therapy
The validity, reliability and acceptability of the SAVASI; a new self‐assessment score in vitiligo - Komen - 2015 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative - ScienceDirect
Figure 1 from Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo | Semantic Scholar
Table 1 from Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. | Semantic Scholar
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial - The Lancet
Ruxolitinib 1.5% to be approved late 2021 to early 2022. Very promising results, especially on the face : r/Vitiligo
AbbVie Announces Upadacitinib Meets Primary Endpoint of Phase 2 Trial for Vitiligo - Advances to Phase 3 - LiVDerm
Scoring systems in dermatology - ppt download
Deux essais randomisés montrent les effets du Ruxolitinib 1,5% crème dans le vitiligo
Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI) | Dermatology and Therapy